There are large coverage gaps in short-term health plans that were approved Wednesday by the Trump administration.
William Halford, PhD, reportedly administered a live attenuated herpes simplex virus vaccine to 17 participants at an off-campus hotel without approval from an institutional review board.
In the United States, legalization of medical cannabis on a statewide basis was associated with a nearly 30% decrease in schedule III (but not schedule II) opioid prescription numbers and dosages for Medicaid patients.
Twenty-eight medical organizations, including AMA, sent letter to Administrator Verma of CMS
In June 2018, the FDA's Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee met and voted against (14-3) the approval of Remoxy upon data review.
The FDA has the ability within its governing laws to reveal to the public the reasons for its decisions to reject or approve drugs.
In order to achieve universal health coverage, stakeholders must focus on the quality of health services, including provision of effective, safe, timely, equitable, integrated, and efficient health services, according to a report published by the World Health Organization.
The American Medical Association House of Delegates has adopted policy to increase the number of people who obtain coverage through the Affordable Care Act by making marketplace plans more affordable.
Can groups with varying viewpoints come together to agree on a set of standards for the accreditation process?
The American Medical Association has committed to working to integrate precision medicine into alternative payment models.
Researchers evaluated the medical literature using terms including early access, compassionate use, pre-approval access, and named-patient programs.
The travel ban on citizens from several Middle Eastern countries has affected several faculty members and students, some of whom were in the process of completing courses or exams that would allow them to apply for residencies.
The White House announced earlier this month a plan to freeze billions of dollars of risk-adjustment payments scheduled to go to insurers through the Affordable Care Act.
Pivotal trials supporting U.S. Food and Drug Administration approvals granted Breakthrough Therapy designation often lack randomization, double-blinding, and control groups.
Despite good intentions, HIPAA is shrouded in myth and misapplication that does more harm than good for both patients and physicians.
CMS issued a proposal to update payment policies, quality provisions, and payment rates for services under the Medicare Physician Fee Schedule on or after January 1, 2019.
Researchers sought to assess the frequency of specific government agencies and organizations in their funding for the review studies.
New laws and regulations designed to limit the use of prescription narcotics may further constrain doctors' ability to treat patients.
Medical safety organizations and advocates from over 20 countries address the use of technologies to reduce errors and establish an international barcode standard for drug labeling and packaging.
The draft guidance, Innovative Approaches for Nonprescription Drug Products, applies to drugs under the New Drug Application (NDA) process and "is intended to extend that NDA pathway to include therapeutic indications that have not, historically, been available for use without a prescription," said Gottlieb in a press statement.
People often reveal detailed, sensitive data about their health via new technologies.
Introduced by the Trump administration in March 2018, the MyHealthEData initiative seeks to broaden patient access to electronic health records and insurance claims information.
In an era in which technology constantly evolves and becomes smarter by the day, it's not surprising that healthcare costs continue to climb.
Utilizing the Healthcare Cost and Utilization Project State Inpatient Databases, changes in insurance coverage and risk adjusted outcomes among adults aged 19 to 44 years who were hospitalized for injuries before and after Medicaid expansion are explored.
System expansions in the current healthcare environment are making clear impacts on clinical care and patient safety.
The US Food and Drug Administration (FDA) has issued draft guidance for industry regarding the science and ethics of including pregnant women in drug development clinical trials.
The denial or delay of visas for international students is disruptive to both the training program and to patient care.
The US Food and Drug Administration has committed to reducing unexpected disruptions in the supply chain of drugs and medical supplies resulting in shortages.
The American College of Physicians has released 7 position statements supporting equality in healthcare for women.
Researchers used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 to examine personal health care access and quality with the Healthcare Access and Quality Index for 195 countries and territories, as well as subnational locations.
Clinical Pain Advisor Articles
- Opioid Use Disorders: Advances in Pharmacotherapy Provide Long-term Results
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Women Frequently Prescribed High Doses of Opioids After Vaginal Delivery
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Medical Cannabis Legalization Associated With Reduced Schedule III Opioid Prescriptions
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- A Physician's Guide to Incorporating Patient Spirituality in Practice
- FDA Taps Social Media to Identify and Assess Emerging Drug Abuse Threats
- Buffered Lidocaine May Be Superior to Nonbuffered Lidocaine for Inferior Alveolar Nerve Block
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Marijuana's Uncertain Status: Closing the Gap Between State and Federal Policies